DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

176.59 4.90 (2.85%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMGN $176.59 2.85%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $177.50
Previous Close $171.69
Daily Range $176.00 - $181.81
52-Week Range $124.76 - $181.81
Market Cap $134.3B
P/E Ratio 23.17
Dividend (Yield) $3.16 (1.8%)
Ex-Dividend Date
Dividend Pay Date
Volume 7,288,701
Average Daily Volume 3,366,491
Current FY EPS $9.61




Drug Makers

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website:

News & Commentary

Amgen Crushes Wall Street's Expectations in Q2, But This Figure Is a Bit Worrisome

Amgen kept its streak alive by easily surpassing the Street's profit forecast in the second-quarter. However, sales of one drug may have left something to be desired.

Oil Skidded 21% During July--and Was a Big Drag on Stocks

Amgen (AMGN) Stock Higher as Barclays Increases Price Target

Amgen Beats on Q2 Earnings & Revenues, Raises Outlook - Analyst Blog

Nasdaq 100 Movers: WFM, AMGN

Tech Stock Owners Looking For Excuses To Take Profit

Stocks Hitting 52-Week Highs

Today's Market: Biotech Earnings Remain Strong, Apple's Next Revamped Product

Fast Money Picks For July 31

Key Takeaways from Amgen's (AMGN) Q2 Earnings Report - Stocks in the News

See More AMGN News...

AMGN's Top Competitors

AMGN $176.59 (2.85%)
Current stock: AMGN
GILD $117.86 (-0.03%)
Current stock: GILD
CELG $131.25 (-0.48%)
Current stock: CELG
$0.00 (0.00%)
Current stock: